Topics

Oasmia Pharmaceutical AB: Oasmia's rights issue has been oversubscribed

06:29 EST 6 Dec 2019 | FinanzNachrichten

The preliminary result of the rights issue in Oasmia Pharmaceutical AB (publ) ("Oasmia" or the "Company"), in which the subscription period ended on 4 December 2019, amounts to 198,329,980 shares ...

Original Article: Oasmia Pharmaceutical AB: Oasmia's rights issue has been oversubscribed

NEXT ARTICLE

More From BioPortfolio on "Oasmia Pharmaceutical AB: Oasmia's rights issue has been oversubscribed"

Quick Search